chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site rash, Vaccination site warmth
Clinical narrative: A little hot to touch at injection site; Rash at injection site; Pain in right side of hip; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE WARMTH (A little hot to touch at injection site) and ARTHRALGIA (Pain in right side of hip) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ARTHRALGIA (Pain in right side of hip). On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). On an unknown date, the patient experienced VACCINATION SITE WARMTH (A little hot to touch at injection site). The patient was treated with PARACETAMOL (TYLENOL ACHES & STRAINS) at an unspecified dose and frequency. On 14-Jan-2021, ARTHRALGIA (Pain in right side of hip) had resolved. At the time of the report, VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE WARMTH (A little hot to touch at injection site) had not resolved.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia
Clinical narrative: aches; chills; fatigue; A spontaneous report was received from a  Consumer concerning a unknown Year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events like myalgia, fatigue and chills.   The patient's medical history was not provided. No relevant concomitant medications were reported.    On 19-JAN-2021, prior to the onset of the events, the patient received their second planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the Anatomical location for prophylaxis of COVID-19 infection.  On 19-JAN-2021, The patient experienced the events like aches, chills and fatique. The patient became fine after 24 hours.  Action taken with mRNA-1273 in response to the events was not reported.   On unknown date the outcome of the events aches chills and fatigue was resolved. At the time of this report, the outcome of the events like aches , chills and fatigue was resolved
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site erythema, Vaccination site induration
Clinical narrative: arm has lumps; red at the site of injection; arm is tender; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jan-2021 and was forwarded to Moderna on 25-Jan-2021.    A spontaneous report was received from a Consumer concerning a 78 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events like myalgia, vaccination site erythema and vaccination site induration.    The patient's medical history was not provided. No relevant concomitant medications were reported.    On 13-jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 041L20A) intramuscularly in the Anatomical location for prophylaxis of COVID-19 infection.  On 21-jan-2021, The patient experienced the events like tender arms. On 22-jan-2021 vaccination site became red. On an unknown date the patient also developed lumps at the vaccination site.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On 22-jan-2021, the outcome of the events like myalgia, vaccination site erythema and vaccination site induration was not resolved. At the time of this report, the outcome of the events events like myalgia, vaccination site erythema and vaccination site induration was not resolved.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Developed Coronavirus; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Developed Coronavirus) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced COVID-19 (Developed Coronavirus). At the time of the report, COVID-19 (Developed Coronavirus) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, COVID-19: positive (Positive) Developed Coronavirus on 11-JAN-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: metallic taste in mouth/licks hand, it takes metallic; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in mouth/licks hand, it takes metallic) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Depression, Cholesterol and Acid reflux (oesophageal). Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), TRIAMTERENE for Blood pressure high, ATORVASTATIN for Cholesterol, ESCITALOPRAM OXALATE (LEXAPRO) for Depression, LISINOPRIL for Hypertension, MULTIVITAMIN & MINERAL for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (metallic taste in mouth/licks hand, it takes metallic). At the time of the report, DYSGEUSIA (metallic taste in mouth/licks hand, it takes metallic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Pain in extremity
Clinical narrative: Swelling of the lymph nodes; Arm soreness got worse; Arm  soreness; A spontaneous report was received from a  Consumer concerning a 55-years-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm soreness, arm soreness got worse, swelling of the lymph nodes .  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 6 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 025L20A) unknown route of administration in the left arm for prophylaxis of COVID-19 infection.  On 7 Jan 2021, the patient experienced the event arm soreness,On 8 Jan 2021, the patient experienced the event arm soreness got worse,On 13 Jan 2021, the patient experienced the event swelling of the lymph nodes.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, arm soreness, arm soreness got worse, swelling of the lymph nodes were ongoing.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: redness on whole arm from elbow to shoulder; itchiness at the injection site.; rash at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness on whole arm from elbow to shoulder), VACCINATION SITE PRURITUS (itchiness at the injection site.) and VACCINATION SITE RASH (rash at the injection site.) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced ERYTHEMA (redness on whole arm from elbow to shoulder), VACCINATION SITE PRURITUS (itchiness at the injection site.) and VACCINATION SITE RASH (rash at the injection site.). At the time of the report, ERYTHEMA (redness on whole arm from elbow to shoulder), VACCINATION SITE PRURITUS (itchiness at the injection site.) and VACCINATION SITE RASH (rash at the injection site.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications given by reporter.  No treatment information given by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jul-2021: Additional information received
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Peripheral swelling
Clinical narrative: big red area on arm; a litte swollen; Fever in arm/ arm was really hot; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ERYTHEMA (big red area on arm), PERIPHERAL SWELLING (a litte swollen) and FEELING HOT (Fever in arm/ arm was really hot) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 030M20A) for COVID-19 vaccination.     no medical history was provided by the reporter.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FEELING HOT (Fever in arm/ arm was really hot). On an unknown date, the patient experienced ERYTHEMA (big red area on arm) and PERIPHERAL SWELLING (a litte swollen). At the time of the report, PAIN IN EXTREMITY (Sore arm), ERYTHEMA (big red area on arm), PERIPHERAL SWELLING (a litte swollen) and FEELING HOT (Fever in arm/ arm was really hot) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment and concomitant edications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: NNI
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Peripheral swelling, Vaccination site warmth
Clinical narrative: tender to the touch; injection site is like run in fever; swollen; red; A spontaneous report was received from a (Consumer) concerning a 48 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events really swollen, red and tender to touch and the injection site is like run in fever.   The patient's medical history was not provided. Thyroid pill concomitant medications were reported.    On 13,jan,2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 04120A)on left arm(non dominant) intramuscularly in the Anatomical location for prophylaxis of COVID-19 infection.  On 13,jan,2021 she experienced swollen,red and  after two days its been looking worse tender to very warm to touch and injection site is like run in fever.  Treatment for symptoms are Claritin and Tylenol. Laboratory details if provided. Action taken with mRNA-1273 in response to the events was not reported.   On 13,jan,2021, the outcome of the events swollen, red and on 23,jan 2021 ,  tender to touch and the injection site is like run in fever. On 25,jan,2021,it very warm to touch and might be infected.   At the time of this report, the outcome of the event(s) swollen, red, tender to touch and the injection site is like run in fever, it very warm to touch and might be infected were unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Urticaria
Clinical narrative: Hives on neck and elbow; Red rash on upper back; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives on neck and elbow) and RASH ERYTHEMATOUS (Red rash on upper back) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042LZ019) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced URTICARIA (Hives on neck and elbow) and RASH ERYTHEMATOUS (Red rash on upper back). At the time of the report, URTICARIA (Hives on neck and elbow) and RASH ERYTHEMATOUS (Red rash on upper back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Pyrexia, Tremor
Clinical narrative: feeling draggy; shaking; 102.4 fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (feeling draggy), TREMOR (shaking) and PYREXIA (102.4 fever) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL), CARVEDILOL, DULOXETINE HYDROCHLORIDE (DULOXETINE [DULOXETINE HYDROCHLORIDE]), ASA, NICOTINAMIDE (VIT B3), CYANOCOBALAMIN (B12-VITAMIN), FISH OIL (OMEGA 3 [FISH OIL]), ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), ASCORBIC ACID (VIT C 25 FRX), ATORVASTATIN and DENOSUMAB (PROLIA).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced FEELING ABNORMAL (feeling draggy), TREMOR (shaking) and PYREXIA (102.4 fever). At the time of the report, FEELING ABNORMAL (feeling draggy), TREMOR (shaking) and PYREXIA (102.4 fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature: 102.4 (High) high fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment Tylenol 600mg  was provided.   Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot
Clinical narrative: Warmth noted down left arm  extending from  injection site; Redness noted down left arm extending from injection site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of FEELING HOT (Warmth noted down left arm  extending from  injection site) and ERYTHEMA (Redness noted down left arm extending from injection site) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 300042698) for COVID-19 vaccination.     Concurrent medical conditions included Depression, Anxiety and Birth control. Concomitant products included QUETIAPINE FUMARATE (SEROQUEL) and CLONAZEPAM for Anxiety, DESOGESTREL, ETHINYLESTRADIOL (MIRVALA 21) for Birth control, BUPROPION HYDROCHLORIDE (WELLBUTRIN) for Depression.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced FEELING HOT (Warmth noted down left arm  extending from  injection site) and ERYTHEMA (Redness noted down left arm extending from injection site). On 27-Jan-2021, FEELING HOT (Warmth noted down left arm  extending from  injection site) and ERYTHEMA (Redness noted down left arm extending from injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: New event added, concomitant medication added, reporter details updated and medical history details updated.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: headaches due to grinding of teeth/possibly the Moderna vaccine; pain and soreness near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches due to grinding of teeth/possibly the Moderna vaccine) and VACCINATION SITE PAIN (pain and soreness near the injection site) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Testosterone (Patient was prescribed testosterone therapy once a week).    On 23-Jan-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced HEADACHE (headaches due to grinding of teeth/possibly the Moderna vaccine) and VACCINATION SITE PAIN (pain and soreness near the injection site). At the time of the report, HEADACHE (headaches due to grinding of teeth/possibly the Moderna vaccine) and VACCINATION SITE PAIN (pain and soreness near the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include testosterone therapy once a week.    Treatment details was not reported by the reporter.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Vaccination site pain
Clinical narrative: chills; nausea; tiredness; soreness in arm; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (soreness in arm), CHILLS (chills), NAUSEA (nausea) and FATIGUE (tiredness) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness in arm). On 17-Jan-2021, the patient experienced CHILLS (chills), NAUSEA (nausea) and FATIGUE (tiredness). On 19-Jan-2021, VACCINATION SITE PAIN (soreness in arm), CHILLS (chills), NAUSEA (nausea) and FATIGUE (tiredness) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.   This case was linked to MOD-2021-014510 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Bursitis
Clinical narrative: bursitis of the left elbow; A spontaneous report was received from a physician concerning a 83 year old male patient who received   Moderna's  Covid 19 vaccine(mRNA1273) experienced bursitis of the left elbow. The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included high blood pressure medications.  The patient received first of two planned dose of mRNA-1273 (039K20A) on 28-JAN-2021  for prophylaxis of Covid 19 infection.  Patient developed Bursitis of the left elbow few days ago.The treatment for the event include amoxicillin.  Action taken with mRNA-1273 in response to the event(s) was not provided/unknown.  The outcome of the event were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives arm, foot, legs; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives arm, foot, legs) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced URTICARIA (Hives arm, foot, legs). At the time of the report, URTICARIA (Hives arm, foot, legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included benadryl.Concomitant medications were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm hurts; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm hurts) in a 45-year-old male adult exposed to mRNA-1273 (Moderna COVID-19 Vaccine) , while the parent received the product for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the parent received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the adult was diagnosed with PAIN IN EXTREMITY (Arm hurts). The Adult was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  At the time of the report, PAIN IN EXTREMITY (Arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No other relevant concomitant medications were mentioned. N o treatment  was given.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Glucose tolerance test, Maternal exposure during pregnancy, Pregnancy test, Ultrasound breast, Ultrasound uterus
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 26-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 007M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (1 drink/month) from 19-Sep-2015 to 13-Oct-2020, Cigarette smoker (5 cigarettes/week) from 19-Sep-2012 to 01-May-2013 and Marijuana use (1 gram/month) from 19-Sep-2015 to 01-Sep-2019. Concurrent medical conditions included Psoriasis (Improvement, no treatment changes) since 01-Jan-2006. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] from 13-Oct-2020 to an unknown date for Pregnancy.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form(s). The patient's last menstrual period was on 08-Sep-2020 and the estimated date of delivery was 15-Jun-2021. On 16-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-third week of the pregnancy. For neonate 1, the birth weight was 3085 grams (6lbs 13oz) with an APGAR score of 8 and 10 at (1, 5 minutes). The outcome was reported as Unknown. On 19-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2020, Ultrasound breast: inconclusive (Inconclusive) Lump on breast during ultrasound. On 13-Oct-2020, Pregnancy test: positive (Positive) Positive. On 10-Jan-2021, Ultrasound uterus: inconclusive (Inconclusive) Small for gestational age, growth scans on 2/22, 3/25, & 4/22 showed normal growth. On 10-Mar-2021, Glucose tolerance test: inconclusive (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Non-invasive pregnancy testing (NIPT) showed low/no risk.   Most recent FOLLOW-UP information incorporated above includes: On 11-Aug-2021: Significant follow up On 12-Aug-2021: Significant FU: PREGNANACY OUTCOME added   as per follow-up 2 received on 12th AUG 2021 updated the following: gestational period, delivery type, birth type, weight of the fetus, and that the patient is breast feeding
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Muscle spasms, Nausea
Clinical narrative: Bad cramps in legs; bad headache in his eyes; chills; Temperature of 102; nauseous; Vomited a little bit; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Bad cramps in legs), HEADACHE (bad headache in his eyes), CHILLS (chills), PYREXIA (Temperature of 102) and NAUSEA (nauseous) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 025J202A) for COVID-19. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 28-Jan-2021, the patient experienced MUSCLE SPASMS (Bad cramps in legs), HEADACHE (bad headache in his eyes), CHILLS (chills), PYREXIA (Temperature of 102), NAUSEA (nauseous) and VOMITING (Vomited a little bit). At the time of the report, MUSCLE SPASMS (Bad cramps in legs), HEADACHE (bad headache in his eyes), CHILLS (chills), PYREXIA (Temperature of 102), NAUSEA (nauseous) and VOMITING (Vomited a little bit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 102 (High) for about a day and a half.         No relevant concomitant medications were reported. No treatment information was provided.    This case was linked to MOD-2021-151679, MOD-2021-151679 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Bad cramps in legs; bad headache in his eyes; chills; Temperature of 102; nauseous; Vomited a little bit; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Bad cramps in legs), HEADACHE (bad headache in his eyes), CHILLS (chills), PYREXIA (Temperature of 102) and NAUSEA (nauseous) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 025J202A) for COVID-19. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 28-Jan-2021, the patient experienced MUSCLE SPASMS (Bad cramps in legs), HEADACHE (bad headache in his eyes), CHILLS (chills), PYREXIA (Temperature of 102), NAUSEA (nauseous) and VOMITING (Vomited a little bit). At the time of the report, MUSCLE SPASMS (Bad cramps in legs), HEADACHE (bad headache in his eyes), CHILLS (chills), PYREXIA (Temperature of 102), NAUSEA (nauseous) and VOMITING (Vomited a little bit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 102 (High) for about a day and a half.         No relevant concomitant medications were reported. No treatment information was provided.    This case was linked to MOD-2021-151679, MOD-2021-151679 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Pyrexia, Vaccination site pain, Vaccination site swelling
Clinical narrative: lymph nodes in the groin area are uncomfortable; sore arm; lump at the injection site; low grade fever of 99.8F; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (lymph nodes in the groin area are uncomfortable), VACCINATION SITE PAIN (sore arm), VACCINATION SITE SWELLING (lump at the injection site) and PYREXIA (low grade fever of 99.8F) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (lymph nodes in the groin area are uncomfortable), VACCINATION SITE PAIN (sore arm), VACCINATION SITE SWELLING (lump at the injection site) and PYREXIA (low grade fever of 99.8F). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, MUSCULOSKELETAL DISCOMFORT (lymph nodes in the groin area are uncomfortable), VACCINATION SITE PAIN (sore arm), VACCINATION SITE SWELLING (lump at the injection site) and PYREXIA (low grade fever of 99.8F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Muscle strain, Musculoskeletal stiffness, Neck pain
Clinical narrative: Pain left side of neck; Feels like a pulled muscle; Can't look to the left; Left shoulder sore; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain left side of neck), MUSCLE STRAIN (Feels like a pulled muscle), MUSCULOSKELETAL STIFFNESS (Can't look to the left) and ARTHRALGIA (Left shoulder sore) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Pain left side of neck), MUSCLE STRAIN (Feels like a pulled muscle), MUSCULOSKELETAL STIFFNESS (Can't look to the left) and ARTHRALGIA (Left shoulder sore). At the time of the report, NECK PAIN (Pain left side of neck), MUSCLE STRAIN (Feels like a pulled muscle), MUSCULOSKELETAL STIFFNESS (Can't look to the left) and ARTHRALGIA (Left shoulder sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Peripheral swelling, Pruritus, Rash erythematous, Rash papular
Clinical narrative: red spots over body; Itching; lips swollen; face swollen; hands swollen; red on cheeks; This spontaneous case was reported by a non-health professional and describes the occurrence of RASH PAPULAR (red spots over body), PRURITUS (Itching), LIP SWELLING (lips swollen), SWELLING FACE (face swollen) and PERIPHERAL SWELLING (hands swollen) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced RASH PAPULAR (red spots over body), PRURITUS (Itching), LIP SWELLING (lips swollen), SWELLING FACE (face swollen), PERIPHERAL SWELLING (hands swollen) and RASH ERYTHEMATOUS (red on cheeks). At the time of the report, RASH PAPULAR (red spots over body), PRURITUS (Itching), LIP SWELLING (lips swollen), SWELLING FACE (face swollen), PERIPHERAL SWELLING (hands swollen) and RASH ERYTHEMATOUS (red on cheeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: red spots over body; Itching; lips swollen; face swollen; hands swollen; red on cheeks; This spontaneous case was reported by a non-health professional and describes the occurrence of RASH PAPULAR (red spots over body), PRURITUS (Itching), LIP SWELLING (lips swollen), SWELLING FACE (face swollen) and PERIPHERAL SWELLING (hands swollen) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced RASH PAPULAR (red spots over body), PRURITUS (Itching), LIP SWELLING (lips swollen), SWELLING FACE (face swollen), PERIPHERAL SWELLING (hands swollen) and RASH ERYTHEMATOUS (red on cheeks). At the time of the report, RASH PAPULAR (red spots over body), PRURITUS (Itching), LIP SWELLING (lips swollen), SWELLING FACE (face swollen), PERIPHERAL SWELLING (hands swollen) and RASH ERYTHEMATOUS (red on cheeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site swelling
Clinical narrative: felt a lump on the arm of injection; swelling; redness; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE MASS (felt a lump on the arm of injection), INJECTION SITE SWELLING (swelling) and INJECTION SITE ERYTHEMA (redness) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 29LZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INJECTION SITE MASS (felt a lump on the arm of injection), INJECTION SITE SWELLING (swelling) and INJECTION SITE ERYTHEMA (redness). At the time of the report, INJECTION SITE MASS (felt a lump on the arm of injection), INJECTION SITE SWELLING (swelling) and INJECTION SITE ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Left arm is itching; vaccination site erythema; vaccination adverse reaction; vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Left arm is itching), VACCINATION SITE PAIN (vaccination site pain), VACCINATION SITE ERYTHEMA (vaccination site erythema) and VACCINATION COMPLICATION (vaccination adverse reaction) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol, Cellulitis, Asthma and Breast cancer since 1998. Concomitant products included ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for High cholesterol.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (vaccination site pain). On 15-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Left arm is itching), VACCINATION SITE ERYTHEMA (vaccination site erythema) and VACCINATION COMPLICATION (vaccination adverse reaction). At the time of the report, VACCINATION SITE PRURITUS (Left arm is itching), VACCINATION SITE PAIN (vaccination site pain), VACCINATION SITE ERYTHEMA (vaccination site erythema) and VACCINATION COMPLICATION (vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details was reported.       Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Non-Significant follow up
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Back pain, Fatigue, Headache, Hypokinesia
Clinical narrative: headache; fever (101.5); fatigue; pain in TMJ left side; stomachache; nausea; back pain; limited motion; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (fever (101.5)), FATIGUE (fatigue), PAIN (pain in TMJ left side) and ABDOMINAL PAIN UPPER (stomachache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 06-Feb-2021, the patient experienced HEADACHE (headache), PYREXIA (fever (101.5)), FATIGUE (fatigue), PAIN (pain in TMJ left side), ABDOMINAL PAIN UPPER (stomachache), NAUSEA (nausea), BACK PAIN (back pain) and HYPOKINESIA (limited motion). At the time of the report, HEADACHE (headache), PYREXIA (fever (101.5)), FATIGUE (fatigue), PAIN (pain in TMJ left side), ABDOMINAL PAIN UPPER (stomachache), NAUSEA (nausea), BACK PAIN (back pain) and HYPOKINESIA (limited motion) outcome was unknown.            This case was linked to MOD-2021-015262 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: headache; fever (101.5); fatigue; pain in TMJ left side; stomachache; nausea; back pain; limited motion; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (fever (101.5)), FATIGUE (fatigue), PAIN (pain in TMJ left side) and ABDOMINAL PAIN UPPER (stomachache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 06-Feb-2021, the patient experienced HEADACHE (headache), PYREXIA (fever (101.5)), FATIGUE (fatigue), PAIN (pain in TMJ left side), ABDOMINAL PAIN UPPER (stomachache), NAUSEA (nausea), BACK PAIN (back pain) and HYPOKINESIA (limited motion). At the time of the report, HEADACHE (headache), PYREXIA (fever (101.5)), FATIGUE (fatigue), PAIN (pain in TMJ left side), ABDOMINAL PAIN UPPER (stomachache), NAUSEA (nausea), BACK PAIN (back pain) and HYPOKINESIA (limited motion) outcome was unknown.            This case was linked to MOD-2021-015262 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypoaesthesia, Nausea
Clinical narrative: Numbness in right Side of Face; Nausea; Dizziness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), DIZZINESS (Dizziness), HEADACHE (Headache) and HYPOAESTHESIA (Numbness in right Side of Face) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced NAUSEA (Nausea), DIZZINESS (Dizziness) and HEADACHE (Headache). On 06-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in right Side of Face). At the time of the report, NAUSEA (Nausea), DIZZINESS (Dizziness), HEADACHE (Headache) and HYPOAESTHESIA (Numbness in right Side of Face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: Vaccination site warth; Vccination site induration; Vaccination site erythema; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site warth), VACCINATION SITE INDURATION (Vccination site induration) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Vaccination site warth), VACCINATION SITE INDURATION (Vccination site induration) and VACCINATION SITE ERYTHEMA (Vaccination site erythema). At the time of the report, VACCINATION SITE WARMTH (Vaccination site warth), VACCINATION SITE INDURATION (Vccination site induration) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was unknown.  She stated all of these occurred about 1 week after the injection.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Follow up received on 25-Mar-2021: Outcome of event was updated.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Red rash on arm after receiving vaccine; A spontaneous report was received from a consumer concerning a 66-years old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event red rash on arm after receiving vaccine/rash.   The patient's medical history was not provided. No relevant concomitant product use was reported.  On 20 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) in the left arm for prophylaxis of COVID-19 infection. The route of administration was unknown.    On an unknown date, the patient experienced rash on arm after receiving vaccine.  No treatment details were provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event rash on arm after receiving vaccine was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Flushing, Headache, Heart rate
Clinical narrative: arm soreness; fatigue; headache; difficulty breathing; tachycardia; heart racing; flush; pins and needles; A spontaneous report was received from a nurse concerning a 37 year old female patient.  The patient's medical history was not provided.  No relevant concomitant medication was reported.  On 02Jan2021, the patient received the first of their first planned doses of mRNA-1273 (lot number 039K2A20) intramuscularly for prophylaxis of COVID-19 infection.  On 02Jan2021, the patient experienced  the feeling of pins and needles over her face and chest, a little flushed, heart racing, difficulty breathing, heart rate 108.  On 03Jan2021, the patient experienced arm soreness, fatigue, and headache.  No treatment was reported.  Action taken with the mRNA-1273 was not reported.  The outcome of the events of tachycardia, flushing, palpitations,  paraesthesia, dyspnoea, pain in extremity, fatigue, and headache, was considered resolved.; Reporter's Comments: This case concerns a 37 year old, female patient, who experienced a non-serious unexpected event of tachycardia, palpitations, flushing, paraesthesia, dyspnea, pain in extremity, and non-serious expected events of fatigue, and headache. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Palpitations, Paraesthesia, Tachycardia
Clinical narrative: arm soreness; fatigue; headache; difficulty breathing; tachycardia; heart racing; flush; pins and needles; A spontaneous report was received from a nurse concerning a 37 year old female patient.  The patient's medical history was not provided.  No relevant concomitant medication was reported.  On 02Jan2021, the patient received the first of their first planned doses of mRNA-1273 (lot number 039K2A20) intramuscularly for prophylaxis of COVID-19 infection.  On 02Jan2021, the patient experienced  the feeling of pins and needles over her face and chest, a little flushed, heart racing, difficulty breathing, heart rate 108.  On 03Jan2021, the patient experienced arm soreness, fatigue, and headache.  No treatment was reported.  Action taken with the mRNA-1273 was not reported.  The outcome of the events of tachycardia, flushing, palpitations,  paraesthesia, dyspnoea, pain in extremity, fatigue, and headache, was considered resolved.; Reporter's Comments: This case concerns a 37 year old, female patient, who experienced a non-serious unexpected event of tachycardia, palpitations, flushing, paraesthesia, dyspnea, pain in extremity, and non-serious expected events of fatigue, and headache. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Magnetic resonance imaging, Muscular weakness, Pain in extremity
Clinical narrative: Arm was a little sore; Shoulder pain due to a cyst that ruptured; muscle weakness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore) and ARTHRALGIA (Shoulder pain due to a cyst that ruptured) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026LZ0A) for COVID-19 vaccination.     Concurrent medical conditions included BRCA1 gene mutation since 07-Apr-2014.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was a little sore) and ARTHRALGIA (Shoulder pain due to a cyst that ruptured). At the time of the report, PAIN IN EXTREMITY (Arm was a little sore) and ARTHRALGIA (Shoulder pain due to a cyst that ruptured) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, Magnetic resonance imaging: normal (normal) Minimal disc bulge at C5-C6 without evidence of spinal canal stenosis or neuroforaminal narrowing. The remainder of cervical spine is within normal limits.. On 08-Jan-2021, Magnetic resonance imaging: abnormal (abnormal) Posterosuperior through superior labral tear..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   This case was linked to MOD-2021-016650 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Height, weight, race and ethnicity of patient were added. Medical history added. Dose 1 and dose 2 details were added. On 01-Jun-2021: MRI details added.